Lannett Adds To Respiratory Pipeline With Spiriva Rival

Extension Of Alliance With Respirent Targets $1.5bn US Brand Sales

 
• By David Wallace
  
Spiriva Handihaler inhaler
Lannett and Respirent are developing a generic Spiriva Handihaler • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business